The odyssey of a gynecologic oncologist

Malignant disease in pregnancy.

Journal of perinatal medicine·2001

Microsatellite instability in human solid tumors.

Cancer·1998

bcl-2 and p53 in endometrial adenocarcinoma.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·1997

P53 expression in adenomyosis in endometrial carcinoma patients.

Gynecologic oncology·1996

Prophylaxis in ovarian cancer.

Cancer·1993

The malpractice crisis in obstetrics and gynecology: is there a solution?

Bulletin of the New York Academy of Medicine·1991

Early-phase vs. late-phase clinical trials in gynecologic oncology: Trends in trial completion, reporting, and enrollment of racial and ethnic minority groups.

Gynecologic oncology·2026

Comparing niraparib versus platinum-taxane doublet chemotherapy as neoadjuvant treatment in patients with newly diagnosed homologous recombination-deficient stage III/IV ovarian cancer: Findings from cohort C of the OPAL phase 2 trial.

Gynecologic oncology·2026

Evaluating a patient ambassador program to improve clinical trial knowledge and intent to discuss gynecologic oncology trials.

Gynecologic oncology·2026

Incidence, prevalence, mortality and survival trends in women with endometrial-, ovarian- and cervical cancer in the Nordic countries (1980-2023) with focus on younger women (0-49 years old).

Gynecologic oncology·2026

Predicting residual disease and extent of surgery after neoadjuvant chemotherapy for ovarian cancer: Does the MSKCC model from the primary setting apply?

Gynecologic oncology·2026

Feedback activation of MAPK-ERK1/2 signaling causes resistance to trastuzumab-deruxtecan in endometrial cancers.

Gynecologic oncology·2026

Revisiting the Incidence and Risk Factors for Cervical Postlaminectomy Kyphosis: A Systematic Review.

Clinical spine surgery·2026

Microenvironment-defined priority pathways shape ICD-driven abscopal responses.

Frontiers in immunology·2026

Mitochondrial remodeling after conventional and ultra-high dose rate irradiation in head and neck carcinoma cells in vitro.

Clinical and translational radiation oncology·2026

Related Experiment Videos

The odyssey of a gynecologic oncologist

Related Concept Videos

Malignant disease in pregnancy.

Microsatellite instability in human solid tumors.

bcl-2 and p53 in endometrial adenocarcinoma.

P53 expression in adenomyosis in endometrial carcinoma patients.

Prophylaxis in ovarian cancer.

The malpractice crisis in obstetrics and gynecology: is there a solution?

Early-phase vs. late-phase clinical trials in gynecologic oncology: Trends in trial completion, reporting, and enrollment of racial and ethnic minority groups.

Comparing niraparib versus platinum-taxane doublet chemotherapy as neoadjuvant treatment in patients with newly diagnosed homologous recombination-deficient stage III/IV ovarian cancer: Findings from cohort C of the OPAL phase 2 trial.

Evaluating a patient ambassador program to improve clinical trial knowledge and intent to discuss gynecologic oncology trials.

Incidence, prevalence, mortality and survival trends in women with endometrial-, ovarian- and cervical cancer in the Nordic countries (1980-2023) with focus on younger women (0-49 years old).

Predicting residual disease and extent of surgery after neoadjuvant chemotherapy for ovarian cancer: Does the MSKCC model from the primary setting apply?

Feedback activation of MAPK-ERK1/2 signaling causes resistance to trastuzumab-deruxtecan in endometrial cancers.

Revisiting the Incidence and Risk Factors for Cervical Postlaminectomy Kyphosis: A Systematic Review.

Microenvironment-defined priority pathways shape ICD-driven abscopal responses.

Mitochondrial remodeling after conventional and ultra-high dose rate irradiation in head and neck carcinoma cells in vitro.

Related Experiment Videos

The odyssey of a gynecologic oncologist

Related Concept Videos

Related Articles